Trial intelligence / Profile preview

Topical tetracycline for prevention of cutaneous loxoscelism

RBR-7jz7hmPhase 3Recruiting

Sponsor
São Paulo Research Foundation
Start
Oct 2018
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of tetracycline and prednisone in Cutaneous loxoscelism (2 arms), sponsored by São Paulo Research Foundation. Started Oct 2018; status: recruiting.

02

Drugs

tetracyclineprednisone
03

Conditions

Cutaneous loxoscelism

Beyond the preview

Go deeper on RBR-7jz7hm.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-7jz7hm.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call